Company Becton, Dickinson and Company
Equities
BDX
US0758871091
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 154.22 USD | -0.80% |
|
-0.19% | -20.53% |
Business description: Becton, Dickinson and Company
- medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.;
- interventional medical equipment (23.9%): surgical instruments, urological care products, etc.;
- diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc.
Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Number of employees: 72,000
Sales by Activity: Becton, Dickinson and Company
| Fiscal Period: September | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
BD Medical (Excl. of BD Interventional) | 947.9Cr | 884.1Cr | 950.2Cr | 1.01TCr | 1.15TCr |
BD Interventional | 423.9Cr | 446.4Cr | 473.6Cr | 498Cr | 521.7Cr |
BD Life Sciences | 653Cr | 556.4Cr | 513.3Cr | 519.1Cr | 516.7Cr |
Other | - | - | - | -6.7Cr | - |
Geographical breakdown of sales: Becton, Dickinson and Company
| Fiscal Period: September | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
United States | 1.1TCr | 1.07TCr | 1.11TCr | 1.17TCr | 1.28TCr |
Europe, The Middle East and Africa (EMEA) | 475.1Cr | 404.3Cr | 424.4Cr | 440.2Cr | 472.9Cr |
Greater Asia | 327.2Cr | 304.7Cr | 291.3Cr | 290.6Cr | 309.3Cr |
Other | 125.5Cr | 105.8Cr | 110.2Cr | 120.7Cr | 122.7Cr |
Executive Committee: Becton, Dickinson and Company
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Polen
CEO | Chief Executive Officer | 53 | 28/01/2020 |
Vitor Roque
DFI | Director of Finance/CFO | 44 | 05/12/2025 |
Denise Fleming
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/07/2022 |
Claudia Curtis
CMP | Compliance Officer | - | 01/02/2023 |
Ronald Silverman
CTO | Chief Tech/Sci/R&D Officer | 56 | 04/12/2023 |
Composition of the Board of Directors: Becton, Dickinson and Company
| Director | Title | Age | Since |
|---|---|---|---|
Bertram Scott
BRD | Director/Board Member | 75 | 24/09/2002 |
| Director/Board Member | 71 | 26/07/2010 | |
Thomas Polen
CHM | Chairman | 53 | 28/04/2021 |
Andy Eckert
BRD | Director/Board Member | 65 | 23/09/2016 |
Timothy Ring
BRD | Director/Board Member | 69 | 29/12/2017 |
| Director/Board Member | 61 | 10/08/2018 | |
Carrie Byington
BRD | Director/Board Member | 63 | 21/10/2021 |
Bill Brown
BRD | Director/Board Member | 64 | 28/02/2022 |
| Director/Board Member | 66 | 24/07/2023 | |
Gregory Hayes
BRD | Director/Board Member | 66 | 26/03/2025 |
Company details: Becton, Dickinson and Company
Group companies: Becton, Dickinson and Company
| Name | Category and Sector |
|---|---|
Becton, Dickinson BV
 Becton, Dickinson BV Medical SpecialtiesHealth Technology Manufactures and wholesales medical, surgical & pharmaceutical products |
Medical Specialties
|
Becton, Dickinson BV
Becton, Dickinson BV Medical SpecialtiesHealth Technology Manufactures and wholesales medical, surgical & pharmaceutical products |
Medical Specialties
|
Becton Dickinson India Pvt Ltd.
 Becton Dickinson India Pvt Ltd. Information Technology ServicesTechnology Services Operates as a medical technology company by improving discovery, diagnostics and the delivery of care |
Information Technology Services
|
Becton Dickinson India Pvt Ltd.
Becton Dickinson India Pvt Ltd. Information Technology ServicesTechnology Services Operates as a medical technology company by improving discovery, diagnostics and the delivery of care |
Information Technology Services
|
Becton Dickinson Euro Finance SARL
 Becton Dickinson Euro Finance SARL Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity |
Finance/Rental/Leasing
|
Other Medical Equipment, Supplies & Distribution
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.80% | -0.19% | -23.57% | -39.25% | 4.39TCr | |
| -2.36% | -2.50% | -20.95% | -2.20% | 17TCr | |
| -0.80% | +0.67% | +5.20% | +7.92% | 11TCr | |
| -0.51% | -1.23% | +12.83% | +93.94% | 6.24TCr | |
| -1.09% | +4.33% | +91.97% | +103.56% | 6.22TCr | |
| -0.20% | +2.98% | - | - | 3.7TCr | |
| -2.53% | +2.89% | -3.21% | -44.24% | 2.46TCr | |
| -0.52% | +1.77% | +0.67% | +15.02% | 2.18TCr | |
| -0.23% | -2.36% | -20.25% | +11.93% | 1.98TCr | |
| -1.35% | +1.63% | -1.18% | -41.57% | 1.95TCr | |
| Average | -1.04% | +1.01% | +4.61% | +11.68% | 5.78TCr | |
| Weighted average by Cap. | -1.30% | +0.31% | +3.55% | +18.02% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BDX Stock
- Company Becton, Dickinson and Company
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition